|
Volumn 37, Issue 1, 2005, Pages 472-476
|
Mean xenograft survival of 14.6 days in a small group of hDAF-transgenic pig hearts transplanted orthotopically into baboons
a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOPHOSPHAMIDE;
CYCLOSPORIN A;
DECAY ACCELERATING FACTOR;
MYCOPHENOLIC ACID;
STEROID;
UNCLASSIFIED DRUG;
XENOREACTIVE ANTIBODY;
ACUTE GRAFT REJECTION;
ACUTE KIDNEY FAILURE;
ANEMIA;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIBODY TITER;
BABOON;
CAUSE OF DEATH;
CONFERENCE PAPER;
CONTROLLED STUDY;
ECHOCARDIOGRAPHY;
GENE FUNCTION;
GRAFT SURVIVAL;
HEART;
HEART EJECTION FRACTION;
HEART FUNCTION;
HEART TRANSPLANTATION;
HEMODYNAMICS;
HISTOLOGY;
ILEUS;
IMMUNOHISTOCHEMISTRY;
IMMUNOSUPPRESSIVE TREATMENT;
NONHUMAN;
NONVIRAL GENE THERAPY;
ORTHOTOPIC TRANSPLANTATION;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SEROLOGY;
SURVIVAL RATE;
SURVIVAL TIME;
SWINE;
TRANSGENIC ANIMAL;
XENOGRAFT;
|
EID: 20144387609
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.12.241 Document Type: Conference Paper |
Times cited : (11)
|
References (11)
|